| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
| 04/25/2002 | US20020049183 Phospholipids, espeically phosphatidylethanolamines, covalently bound to physiologically acceptable monomers or polymers. |
| 04/25/2002 | US20020049171 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 04/25/2002 | US20020049156 Polyhudroxy glycopeptide derivatives |
| 04/25/2002 | US20020048801 Peptide with enzymatic activity; for use as diagnostic tools in detecting cancer and cardiovascular and liver disorders |
| 04/25/2002 | US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048748 Controlling human lymphocyte leukemia/lymphoma viruses immunodeficiency virus; obtain human, administer viricide and interleukin, monitor human for adjust in viral activity |
| 04/25/2002 | US20020048611 Anti-microbial-adhesion fraction derived from vaccinium |
| 04/25/2002 | US20020048587 Containing an antigen or at least one in vivo generator of a compound comprising an amino acid sequence. |
| 04/25/2002 | US20020048584 Patients that are treated with HAART are then treated with an intensification regimen wherein hydroxyurea and didanosine (ddI) are given; followed by addition of compounds, such as OKT3 and IL-2, that activate latently infected cells |
| 04/25/2002 | US20020048583 Combining ex vivo an antigen and an antigen-presenting cell binding agent specific for the antigen, and administering the composition to a patient suffering from a disease associated with the antigen |
| 04/25/2002 | US20020048576 Enzyme that cleaves a linkage that effects release of a cell-surface protein or carbohydrate and a physiologically acceptable carrier for said enzyme; form suitable for oral administration. |
| 04/25/2002 | US20020048570 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048569 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048568 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 04/25/2002 | US20020048567 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | DE10051320A1 New 2-(4-amino-piperidin-1-yl)-2-aryl-N-(phenylalkyl)-acetamides, are neurokinin antagonists having a long duration of action, useful e.g. for treating allergic, inflammatory or central nervous system diseases |
| 04/25/2002 | CA2464092A1 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | CA2463678A1 Assay for directly detecting a rs virus related biological cell in a body fluid sample |
| 04/25/2002 | CA2426593A1 Ketolide antibacterials |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426381A1 Cell damage inhibitor |
| 04/25/2002 | CA2426366A1 Fusion cells and cytokine compositions for treatment of disease |
| 04/25/2002 | CA2426271A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | CA2426148A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425900A1 Novel medicinal herbal composition for treating liver diseases and hiv |
| 04/25/2002 | CA2425727A1 Methods and compositions for promoting the maturation of monocytes |
| 04/25/2002 | CA2425522A1 Ribavirin-pegylated interferon alfa hcv combination therapy |
| 04/25/2002 | CA2425221A1 Protein c or activated protein c-like molecules |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/25/2002 | CA2420012A1 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance |
| 04/24/2002 | EP1199372A2 Polymorphisms in the human P2X7 gene |
| 04/24/2002 | EP1199368A2 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 04/24/2002 | EP1199307A1 Pharmaceutically active benzoquinazoline compounds |
| 04/24/2002 | EP1199079A2 Use of plant extract for treatment and prevention of sore throats |
| 04/24/2002 | EP1199077A1 Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers |
| 04/24/2002 | EP1199067A2 Prophylactic use of N-Methyl-D-Aspartate (NMDA) antagonists |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198473A1 Pseudomycin amide and ester analogs |
| 04/24/2002 | EP1198472A1 Amine-modified pseudomycin compounds |
| 04/24/2002 | EP1198471A1 Process for deacylation of lipodepsipeptides |
| 04/24/2002 | EP1198470A1 Pseudomycin prodrugs |
| 04/24/2002 | EP1198468A1 Stabilized viral envelope proteins and uses thereof |
| 04/24/2002 | EP1198467A1 5-nitrofurfural derivatives |
| 04/24/2002 | EP1198463A2 Compounds for use in treatment of neurological disorders |
| 04/24/2002 | EP1198454A1 Mutilin derivatives and their use as antibacterials |
| 04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/24/2002 | EP1198254A2 Carrier-drug conjugate |
| 04/24/2002 | EP1198249A2 Use of cpg as an adjuvant for hiv vaccine |
| 04/24/2002 | EP1198248A2 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 04/24/2002 | EP1198245A2 Use of purified invaplex from gram negative bacteria as a vaccine |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | EP1198237A1 Herbal compositions for itchy or infected skin |
| 04/24/2002 | EP1198233A1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 04/24/2002 | EP1198232A1 Urea substituted imidazoquinolines |
| 04/24/2002 | EP1051180B1 Phospholipids having antimicrobial activity with the presence of antimicrobials |
| 04/24/2002 | EP0991646B1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same |
| 04/24/2002 | CN1346406A Human ubiquitin ligase E3 for the modulation of NF-kappa 8 |
| 04/24/2002 | CN1346367A HIV peptides, antigens, vaccine compositions, immunoassay kit and method of detecting |
| 04/24/2002 | CN1346366A Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 04/24/2002 | CN1346365A Macrocylic peptides active against the hepatitis C virus |
| 04/24/2002 | CN1346363A The novel antisense-oligos with better stability and antisense effect |
| 04/24/2002 | CN1346361A Ether type lipid A1-carboxylic acid analogues |
| 04/24/2002 | CN1346360A Phosphoramidate, and mono-di, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-YL)-2-cyclopentene-1-methanol as antiviral agents |
| 04/24/2002 | CN1346356A 治疗性的核苷化合物 Therapeutic nucleoside compound |
| 04/24/2002 | CN1346353A Farnesy transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346283A External coated chewing gum products |
| 04/24/2002 | CN1346276A Biodegradable and biocompatible polymeric microsphores encapsulating salmonella enteritidis bacteria |
| 04/24/2002 | CN1346272A Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 04/24/2002 | CN1345883A Macroweb bombinator antisperm polypeptide and its preparation process and use in medicine |
| 04/24/2002 | CN1345775A Polypeptide for preventing, diagnosis and treating hepatitis E virus and used as diagnostic reagent and vaccine |
| 04/24/2002 | CN1345728A Solasodine hydrochlorate and productive method and application in medicine |
| 04/24/2002 | CN1345727A Aqueous soluble steroid compound alkaloid salt, preparation process and medicinal composition containing same |
| 04/24/2002 | CN1345603A Composite disinfection live vaccin for rainbow virus or streptococcus infection and complication thereof of fishes |
| 04/24/2002 | CN1345599A Oral cavity bacteriostatic composition containing extract of Chinese herb lotus leaf |
| 04/24/2002 | CN1083453C Fused imidazole derivatives as emultidrug resistance modulators |
| 04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 04/24/2002 | CN1083438C Substituted dismino-1,3,5-triazine derivatives |
| 04/24/2002 | CN1083264C Pharmaceutical compositions comprising an opiate ant agonist and calcium salts, their use for the treatment of endorphin-mediated pathlogies |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376548 Enhanced propertied pesticides |
| 04/23/2002 | US6376547 N,n-substituted of glycine |
| 04/23/2002 | US6376526 For huans, animals |
| 04/23/2002 | US6376522 Microbiocides |
| 04/23/2002 | US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 04/23/2002 | US6376504 Phenethyl-5-bromopyridlythiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DBABO) derivatives exhibiting spermicidal activity |
| 04/23/2002 | US6376497 Excellent, wide-spectrum antifungal activities and low toxicity |
| 04/23/2002 | US6376496 Inhibitors of prenyl-protein transferase |
| 04/23/2002 | US6376493 Selective inhibition of phosphodiesterase iv and tumor necrosis factor; useful in treating osteoporosis, tumors, autoimmune diseases, rheumatic diseases, and asthma |
| 04/23/2002 | US6376491 Benzofuran derivatives for treatment or prevention of mycosis in mammals |
| 04/23/2002 | US6376489 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/23/2002 | US6376473 Polynucleotide vaccine formula in particular against bovine respiratory pathology |
| 04/23/2002 | US6376459 Specific for gp39 on t cells was able to inhibit helper t-cell mediated b-cell activation by binding to a novel 39 kd protein receptor on helper t-cell membranes |
| 04/23/2002 | US6376228 Heterophil-adapted poultry vaccine |
| 04/23/2002 | US6376214 DNA encoding a novel homolog of CSBP/p38 MAP kinase |
| 04/23/2002 | US6375975 Pharmaceutical compositions for buccal and pulmonary application |
| 04/23/2002 | US6375952 Isolated herpes simplex virus polypeptide |